AJP - Lung  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 280: L748-L754, 2001;
1040-0605/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fisher, A. B.
Right arrow Articles by Dodia, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fisher, A. B.
Right arrow Articles by Dodia, C.
Vol. 280, Issue 4, L748-L754, April 2001

Lysosomal-type PLA2 and turnover of alveolar DPPC

Aron B. Fisher and Chandra Dodia

Institute for Environmental Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

This study evaluated the role of a lysosomal-type phospholipase A2 (aiPLA2) in the degradation of internalized dipalmitoylphosphatidylcholine (DPPC) and in phospholipid synthesis by the rat lung. Uptake and degradation of DPPC were measured in isolated perfused rat lungs over 3 h following endotracheal instillation of [3H]DPPC in mixed unilamellar liposomes plus or minus MJ33, a specific inhibitor of lung aiPLA2. Uptake of DPPC was calculated from total tissue-associated radiolabel, and degradation was calculated from the sum of radiolabel in degradation products. Both uptake and degradation were markedly stimulated by addition of 8-bromo-cAMP to the perfusate. MJ33 had no effect on DPPC uptake but decreased DPPC degradation at 3 h by ~40-50%. The effect of MJ33 on lung synthesis of DPPC was evaluated with intact rats over a 12- to 24-h period following intravenous injection of radiolabeled palmitate and choline. MJ33 treatment decreased palmitate incorporation into disaturated phosphatidylcholine of lamellar bodies and surfactant by ~65% at 24 h but had no effect on choline incorporation. This result is compatible with inhibition of the deacylation/reacylation pathway for DPPC synthesis. These results obtained with intact rat lungs indicate that aiPLA2 is a major enzyme for degradation of internalized DPPC and also has an important role in DPPC synthesis.

alveolar type II cells; dipalmitoylphosphatidylcholine; phospholipase A2 inhibitors; phospholipid synthesis; endocytosis


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
Y. Manevich, K. S. Reddy, T. Shuvaeva, S. I. Feinstein, and A. B. Fisher
Structure and phospholipase function of peroxiredoxin 6: identification of the catalytic triad and its role in phospholipid substrate binding
J. Lipid Res., October 1, 2007; 48(10): 2306 - 2318.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Abe, M. Hiraoka, and J. A. Shayman
Positional specificity of lysosomal phospholipase A2
J. Lipid Res., October 1, 2006; 47(10): 2268 - 2279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. R. Bates, J.-Q. Tao, H. L. Collins, O. L. Francone, and G. H. Rothblat
Pulmonary abnormalities due to ABCA1 deficiency in mice
Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L980 - L989.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. B. Fisher, C. Dodia, S. I. Feinstein, and Y.-S. Ho
Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2
J. Lipid Res., June 1, 2005; 46(6): 1248 - 1256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Ruckert, S. R. Bates, and A. B. Fisher
Role of clathrin- and actin-dependent endocytotic pathways in lung phospholipid uptake
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L981 - L989.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Jain, C. Dodia, S. R. Bates, S. Hawgood, F. R. Poulain, and A. B. Fisher
SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues
Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L759 - L765.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online